Epigenetic regulators of neuronal ferroptosis identify novel therapeutics for neurological diseases: HDACs, transglutaminases, and HIF prolyl hydroxylases
A major thrust of our laboratory has been to identify how physiological stress is transduced into transcriptional responses that feed back to overcome the inciting stress or its consequences, thereby fostering survival and repair. To this end, we have adopted the use of an in vitro model of ferropto...
Main Authors: | Orjon Rroji, Amit Kumar, Saravanan S. Karuppagounder, Rajiv R. Ratan |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-01-01
|
Series: | Neurobiology of Disease |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0969996120304204 |
Similar Items
-
Neuroprotective Effect of HIF Prolyl Hydroxylase Inhibition in an In Vitro Hypoxia Model
by: Maria Savyuk, et al.
Published: (2020-07-01) -
HIF prolyl hydroxylase inhibition protects skeletal muscle from eccentric contraction-induced injury
by: Andrew N. Billin, et al.
Published: (2018-11-01) -
Lack of activity of recombinant HIF prolyl hydroxylases (PHDs) on reported non-HIF substrates
by: Matthew E Cockman, et al.
Published: (2019-09-01) -
Network activity in primary hippocampal cultures upon HIF-prolyl hydroxylase inhibition
by: Savyuk, Maria Olegovna, et al.
Published: (2021-05-01) -
Inhibition of HIF-prolyl 4-hydroxylases as a promising approach to the therapy of cardiometabolic diseases
by: K A Aitbaev, et al.
Published: (2018-08-01)